Perspective Therapeutics (CATX) Other Gross PP&E Adjustments (2016 - 2025)
Perspective Therapeutics (CATX) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with $79.2 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 39.91% to $79.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $79.2 million through Dec 2025, up 39.91% year-over-year, with the annual reading at $79.2 million for FY2025, 39.91% up from the prior year.
- Other Gross PP&E Adjustments hit $79.2 million in Q4 2025 for Perspective Therapeutics, up from $68.0 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $79.2 million in Q4 2025 to a low of $296000.0 in Q4 2022.
- Historically, Other Gross PP&E Adjustments has averaged $25.5 million across 5 years, with a median of $14.0 million in 2023.
- Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 96.6% in 2022 and later surged 1820.11% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at $8.7 million in 2021, then crashed by 96.6% to $296000.0 in 2022, then soared by 896.28% to $2.9 million in 2023, then soared by 1820.11% to $56.6 million in 2024, then soared by 39.91% to $79.2 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for CATX at $79.2 million in Q4 2025, $68.0 million in Q3 2025, and $65.3 million in Q2 2025.